Penn Medicine at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Penn Medicine brings 4 presentations to ASH 2026 in New Orleans, and exhibits at Booth 130. Its program spans myelofibrosis care, sickle cell trial design and CAR T-cell therapy. Work covers differences between academic and community myelofibrosis care and CD5-negative T-cell persistence.
| Organization | ASH 2026 Attendance |
|---|---|
Penn Medicine Philadelphia, PA | |
University of Pennsylvania's academic health system; its Abramson Cancer Center provides cancer care across hospitals in Pennsylvania, New Jersey and Delaware. | Booth Exhibiting at Booth 130 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Talk Sat Dec 12 6:00pm–8:00pm Talk Sun Dec 13 4:30pm–6:00pm Session Sun Dec 13 4:30pm–6:00pm Real-World Data Applications in Sickle Cell Disease Trial Design Using sickle cell disease registries and health records to build external control arms, track safety after approval, and define pain as a trial endpoint. Talk Sun Dec 13 4:30pm–6:00pm |
Find decision makers at Penn Medicine
Tell us what you sell and we’ll find the people at Penn Medicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction